Access

Reaching patients around the world

Innovation only makes a difference when it reaches people in need, and making sure they have access to our products is increasingly important.  

Factors such as ageing populations and more complex health challenges are putting pressure on communities and healthcare systems. Accessible healthcare solutions, which can help to prevent and treat chronic conditions and infectious diseases, are an important tool to help economies, people and societies to thrive. 

Challenges to access, and uptake of, medicines and vaccines vary across individuals, communities and countries. They can include affordability; differences in healthcare infrastructure; and stigma and discrimination around accessing certain healthcare options.  

Access starts with understanding patients – who they are, how a disease affects them and the context in which they access care – so that we can reach them in the right way with innovation that is relevant to them. 

We work with communities, payers, regulators and policymakers to help strengthen health systems and get the right products to the right people.

Access in numbers

Going further to enable access in lower income countries

We’re reaching people and patients every day through our global health access partnerships. We understand the challenges faced by people in lower income countries, and we partner with those who have the right capabilities, reach and local knowledge to ensure our products reach people who need them. Our Global Health activities in lower income countries are a key driver of this and have already impacted 1.3 billion lives. 

We focus on accessibility, affordability and availability with the end goal of expanding access to vaccines and medicines from our pipeline and portfolio that have the potential to change the trajectory of high-burden infectious diseases in lower income countries. 

We’re committed to systematically evaluating our pipeline of global health and commercial assets to identify products that have potential global health impact. Working together with partners, we can identify which products will benefit people most in these countries to develop and implement access plans to reach them.  

Achieving our ambition requires focus, stamina and partnership. To succeed, the countries themselves must be at the centre of the process. 

To achieve this commitment, we’re guided by a set principles and key enablers. These include: 

• Robust and evidence-based process and governance 
• Prioritising for high impact, driven by local needs, priorities, insights and experience 
• Ensuring impact and sustainability through innovative partnerships and local capacity building 
• Recognising that no one size fits all 

GSK's global health commitment

Access to HIV medicines

ViiV Healthcare is dedicated to widening access to ensure those who need HIV medicines can receive them. They also collaborate with organisations to enable access to medicines in countries around the world.

ViiV’s voluntary licence agreements allow generic manufacturers to develop paediatric formulations of our medicines where the vast majority of children living with HIV live.

Find out more about how ViiV is working to improve access